Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Identifying anatomical and cell-type human brain proteome changes in multiple sclerosis

EF 2023-24

Résumé
Multiple sclerosis (MS) is a neurodegenerative disease that affects an estimated 90,000 people in Canada. The disease causes demyelination of nerve fibers in the brain which are required for transmission of electrical impulses. These disruptions can lead to a variety of symptoms for patients with MS, such as lack of coordination, impaired sensation, and cognitive impairment. The cause of MS is unknown, with current evidence suggesting a combination of risk factors including viral infection, genetics, and environmental elements. Proteins are primary functional units in biology with key roles in a variety of processes including structural support, signalling pathways, and molecule transport. Mass spectrometry-based proteomics is the quantitative study of all proteins in cellular tissues and is often used to find trends caused by different biological conditions, such as pathway-linked proteins up or down-regulated by disease development. My project involves investigating protein changes in human brains associated with MS pathogenesis. Using autopsied brain tissues from patients with and without MS, I plan to identify proteins dysregulated in MS using mass spectrometry and computational analysis. Studies have shown disease progression differences between lesions in distinct brain regions, suggesting that MS development may vary by location. As such, I will study protein levels in different regions of the brain to investigate the effects of demyelination on area-based protein expression. Gene enrichment analysis would then be performed on these datasets to identify disrupted biological pathways in these regions. Discovering disease-dependent protein changes would be a key step towards expanding biological models on MS development and finding potential treatment targets.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506189
Name
Wang Henry
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying anatomical and cell-type human brain proteome changes in multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Human Brain; Mass Spectrometry; Multiple Sclerosis; Proteomics
Abstract
Multiple sclerosis (MS) is a neurodegenerative disease that affects an estimated 90,000 people in Canada. The disease causes demyelination of nerve fibers in the brain which are required for transmission of electrical impulses. These disruptions can lead to a variety of symptoms for patients with MS, such as lack of coordination, impaired sensation, and cognitive impairment. The cause of MS is unknown, with current evidence suggesting a combination of risk factors including viral infection, genetics, and environmental elements. Proteins are primary functional units in biology with key roles in a variety of processes including structural support, signalling pathways, and molecule transport. Mass spectrometry-based proteomics is the quantitative study of all proteins in cellular tissues and is often used to find trends caused by different biological conditions, such as pathway-linked proteins up or down-regulated by disease development. My project involves investigating protein changes in human brains associated with MS pathogenesis. Using autopsied brain tissues from patients with and without MS, I plan to identify proteins dysregulated in MS using mass spectrometry and computational analysis. Studies have shown disease progression differences between lesions in distinct brain regions, suggesting that MS development may vary by location. As such, I will study protein levels in different regions of the brain to investigate the effects of demyelination on area-based protein expression. Gene enrichment analysis would then be performed on these datasets to identify disrupted biological pathways in these regions. Discovering disease-dependent protein changes would be a key step towards expanding biological models on MS development and finding potential treatment targets.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Henry
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~